Discover how dead tumor cells could enhance chemotherapy and radiotherapy by exposing antigens that help the immune system identify cancer.
As tumors expand beyond their blood supply or succumb to treatments such as chemotherapy and radiation therapy, individual cancer cells eventually die. This process exposes the internal structures of these cells, known as scaffolds. These dead cells serve as a rich source of mutated proteins, or antigens, which can distinguish cancer cells from healthy ones.
The immune system relies on recognizing specific antigens to differentiate between normal body tissues and foreign invaders like tumors. By providing an abundant supply of these antigens through the death of tumor cells, it becomes easier for the immune system to recognize and target cancer cells more effectively.
This approach could potentially improve the efficacy of current cancer treatments by leveraging the body's natural defenses against disease. Understanding how dead tumor cells contribute to antigen production may pave the way for new strategies that enhance the effectiveness of chemotherapy and radiotherapy protocols in clinical settings.
